Outcome of three Phase I trials of the marine compound ES-285 (3 hour infusion) in patients with refractory solid tumors
Schöffski, P.; Grunwald, V.; Giaccone, G.; Salazar, R.; Majem, M.; Dumez, H.; Casado, E.; de las Heras, B.; Armand, J. (2008). Outcome of three Phase I trials of the marine compound ES-285 (3 hour infusion) in patients with refractory solid tumors. European journal of cancer. Supplement (1990) 6(12): 56-56. dx.doi.org/10.1016/S1359-6349(08)72108-6
In: European Journal of Cancer. Supplement (1990). Elsevier: United Kingdom. ISSN 1359-6349, more